Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
Clinical trial NCT01519661 · COMPLETED
Trial details
- NCT number
- NCT01519661
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-01-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.